A-to-I mRNA editing: Why not simply incorporate inosine during mRNA synthesis?

Authors

Yuange Duan, Jiayi Wang, Qi Cao

Published in

Molecular biology reports. Volume 53. Issue 1. Jul 27, 2026. Epub Jul 27, 2026.

Abstract

Adenosine-to-inosine (A-to-I) mRNA editing, catalyzed by ADAR enzymes, is a pervasive post-transcriptional mechanism that diversifies transcriptomes and protects against innate immune activation. This study asks a fundamental "why not" question: why organisms edit adenosine to inosine rather than directly incorporating inosine during mRNA synthesis? We argue that while inosine triphosphate (ITP) could theoretically serve as a transcriptional substrate, its biochemical, regulatory, and evolutionary constraints potentially make this mechanism less feasible. Direct inosine incorporation might replace guanosine instead of adenosine, disrupt editing precision, abolish transcriptomic diversity, and reduce transcriptional/translational efficiency. The universal ITP-to-IMP pathway might reflect the evolutionary pressure to prevent inosine accumulation. Thus, A-to-I RNA editing seems to be a safer, spatially confined solution that reconciles molecular flexibility with genomic fidelity. Understanding why life edits rather than encodes inosine reveals the deep evolutionary logic guiding RNA modification systems.

PMID:
42507190
Bibliographic data and abstract were imported from PubMed on 27 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.